Goodness-of-fit test for monotone proportional subdistribution hazards assumptions based on weighted residuals

被引:5
作者
Boher, Jean-Marie [1 ,2 ]
Filleron, Thomas [3 ]
Giorgi, Roch [2 ,4 ]
Kramar, Andrew [5 ]
Cook, Richard J. [6 ]
机构
[1] Inst Paoli Calmettes, Unite Biostat & Methodol, Marseille, France
[2] Aix Marseille Univ, INSERM, IRD, SESSTIM,Sci Econ & Sociales Sante & Traitement In, Marseille, France
[3] Inst Claudius Regaud, IUCT O, Cellule Biostat, Bur Essais Clin, Toulouse, France
[4] Hop La Timone, AP HM, Serv Biostat & Technol Informat & Commun, Marseille, France
[5] Ctr Oscar Lambret, Unite Methodol & Biostat, Lille, France
[6] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON N2L 3G1, Canada
关键词
competing risks; cumulative incidence functions; proportional subdistribution hazards; goodness-of-fit test; COMPETING RISKS; REGRESSION-MODEL; CUMULATIVE SUMS; COX REGRESSION; BREAST-CANCER; CHECKING; RATIOS;
D O I
10.1002/sim.7153
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recently goodness-of-fit tests have been proposed for checking the proportional subdistribution hazards assumptions in the Fine and Gray regression model. Zhou, Fine, and Laird proposed weighted Schoenfeld-type residuals tests derived under an assumed model with specific form of time-varying regression coefficients. Li, Sheike, and Zhang proposed an omnibus test based on cumulative sums of Schoenfeld-type residuals. In this article, we extend the class of weighted residuals tests by allowing random weights of Schoenfeld-type residuals at ordered event times. In particular, it is demonstrated that weighted residuals tests using monotone weight functions of time are consistent against monotone proportional subdistribution hazards assumptions. Extensive Monte Carlo studies were conducted to evaluate the finite-sample performance of recent goodness-of-fit tests. Results from simulation studies show that weighted residuals tests using monotone random weight functions commonly used in non-proportional hazards regression settings tend to be more powerful for detecting monotone departures than other goodness-of-fit tests assuming no specific time-varying effect or misspecified time-varying effects. Two examples using real data are provided for illustrations. Copyright (C) 2016 John Wiley & Sons, Ltd.
引用
收藏
页码:362 / 377
页数:16
相关论文
共 25 条
  • [1] Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer
    Anderson, William F.
    Chen, Bingshu E.
    Jatoi, Ismail
    Rosenberg, Philip S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 (01) : 121 - 126
  • [2] Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies
    Blaise, Didier
    Farnault, Laure
    Faucher, Catherine
    Marchetti, Nicholas
    Furst, Sabine
    El Cheikh, Jean
    Ladaique, Patrick
    Vey, Norbert
    Bouabdallah, Reda
    Stoppa, Anne-Marie
    Lemarie, Claude
    Calmels, Boris
    Prebet, Thomas
    Castagna, Luca
    Chabannon, Christian
    Mohty, Mohamad
    Esterni, Benjamin
    [J]. EXPERIMENTAL HEMATOLOGY, 2010, 38 (12) : 1241 - 1250
  • [3] Choice and interpretation of statistical tests used when competing risks are present
    Dignam, James J.
    Kocherginsky, Maria N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (24) : 4027 - 4034
  • [4] A proportional hazards model for the subdistribution of a competing risk
    Fine, JP
    Gray, RJ
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (446) : 496 - 509
  • [5] Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified
    Grambauer, Nadine
    Schumacher, Martin
    Beyersmann, Jan
    [J]. STATISTICS IN MEDICINE, 2010, 29 (7-8) : 875 - 884
  • [6] GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515
  • [7] Gray R., 2014, cmprsk: Subdistribution Analysis of Competing Risks. R package version 2.2.7
  • [8] Time-dependence of hazard ratios for prognostic factors in primary breast cancer
    Hilsenbeck, SG
    Ravdin, PM
    de Moor, CA
    Chamness, GC
    Osborne, CK
    Clark, GM
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 227 - 237
  • [9] Androgen Deprivation Therapy and Competing Risks
    Kelly, William K.
    Gomella, Leonard G.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (21): : 2382 - 2383
  • [10] Cumulative incidence in competing risks data and competing risks regression analysis
    Kim, Haesook T.
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (02) : 559 - 565